DOSSIER · 13F Holders · Q1 2026Healthcare · In Vitro & In Vivo Diagnostic Substances
MYGN
MYRIAD GENETICS INC
218 institutions still hold MYRIAD GENETICS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 62855J104·In Vitro & In Vivo Diagnostic Substances·218 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
218 institutions reported MYGN in Q1 2026. ORBIMED ADVISORS LLC leads at 28.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 11
198 more holders available. Log in →